Abstract
SARS-CoV-2 Nucleocapsid protein considered as a vaccine target. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 in different geographical locations considered as an important factor in order to produce a global vaccine for the pandemic. The present investigation relies on the analysis of the similarities and differences of the SARS-CoV-2 Nucleocapsid protein from various geographical locations, considering certain protein parameters, as well as the study of the alignment of the protein sequence of amino acids...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
